Vivos Therapeutics (VVOS) Net Cash Flow (2020 - 2026)
Vivos Therapeutics (VVOS) reported Net Cash Flow of $81000.0 for Q1 2026, up 102.07% year-over-year from $40085.6 in Q1 2025, and up 108.03% on a QoQ basis from -$1.0 million in Q4 2025.
Vivos Therapeutics (VVOS) has 7 years of Net Cash Flow data on file, last reported at $81000.0 in Q1 2026.
- Quarterly Net Cash Flow rose 102.07% year-over-year to $81000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.7 million (down 4246.47% YoY) and the FY2025 annual result came in at -$4.2 million, down 191.64% from the prior year.
- Net Cash Flow improved to $81000.0 in Q1 2026 per VVOS's latest filing, from -$1.0 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $4.3 million in Q2 2024 and bottomed at -$9.4 million in Q2 2025.
- The 5-year median for Net Cash Flow is -$1.4 million (2025), against an average of -$2.0 million.
- The widest annual swing landed in 2024, when Net Cash Flow jumped 236.47%; it then slumped 1878.43% in 2025.
- Tracing VVOS's Net Cash Flow over 5 years: stood at -$3.2 million in 2022, then surged by 122.06% to $703000.0 in 2023, then slumped by 107.25% to -$51000.0 in 2024, then tumbled by 1878.43% to -$1.0 million in 2025, then surged by 108.03% to $81000.0 in 2026.
- Per Business Quant, the three latest VVOS Net Cash Flow figures stand at $81000.0 (Q1 2026), -$1.0 million (Q4 2025), and -$1.4 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -1.11 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -159.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | -503.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -500.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 202.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.19 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 20.30 Mn |
| 10 | Vivos Therapeutics | 9.87 Mn | 7.64 Mn | 3.06 Mn | 81,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81,000.00 |
| Mar 31, 2026 | 81,000.00 |
| Dec 31, 2025 | -1.01 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Jun 30, 2025 | -9.41 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Mar 31, 2025 | -3.92 Mn |
| Dec 31, 2024 | -11,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Sep 30, 2024 | -605,000.00 |
| Sep 30, 2024 | -605,000.00 |
| Jun 30, 2024 | 4.24 Mn |
| Jun 30, 2024 | 4.24 Mn |
| Mar 31, 2024 | 984,000.00 |
| Mar 31, 2024 | 984,000.00 |
| Dec 31, 2023 | 703,000.00 |
| Dec 31, 2023 | 703,000.00 |
| Sep 30, 2023 | -2.96 Mn |
| Sep 30, 2023 | -2.96 Mn |
| Jun 30, 2023 | -3.10 Mn |
| Jun 30, 2023 | -3.10 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Mar 31, 2023 | 3.53 Mn |
| Dec 31, 2022 | -3.20 Mn |
| Dec 31, 2022 | -3.20 Mn |
| Sep 30, 2022 | -6.00 Mn |
| Sep 30, 2022 | -6.00 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Mar 31, 2022 | -6.22 Mn |
| Mar 31, 2022 | -6.22 Mn |
| Dec 31, 2021 | -4.50 Mn |
| Dec 31, 2021 | -4.50 Mn |
| Sep 30, 2021 | -5.66 Mn |
| Sep 30, 2021 | -5.66 Mn |
| Jun 30, 2021 | 20.18 Mn |
| Jun 30, 2021 | 20.18 Mn |
| Mar 31, 2021 | -4.19 Mn |
| Mar 31, 2021 | -4.19 Mn |
| Dec 31, 2020 | 16.64 Mn |
| Dec 31, 2020 | 16.64 Mn |
| Sep 30, 2020 | 1.14 Mn |
| Sep 30, 2020 | 1.14 Mn |
| Jun 30, 2020 | 306,866.00 |
| Jun 30, 2020 | 306,866.00 |
| Mar 31, 2020 | -362,599.00 |
| Mar 31, 2020 | -362,599.00 |